Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:13 PM
Ignite Modification Date:
2025-12-24 @ 2:13 PM
NCT ID:
NCT02372695
Eligibility Criteria:
Inclusion Criteria:
* Patients aged between 50 and 75 years.
* Chronic kidney disease stage 5 D or 4-5 No D as calculated glomerular filtration rate (MDRD).
* Concentration of intact parathyroid hormone (iPTH): 150-400 pg/ml.
* Plasma concentrations of 25 (OH) vitamin D \<30 ng/ml.
* Without vitamin D supplementation for 3 months before the study.
* Serum P\> 3.8 mg / dl.
* Serum Ca\> 9.8 mg / dl.
* No history of cardiovascular events (angina or myocardial infarction, stroke, peripheral arterial disease).
* No exclusion criteria for the use of contrast.
Exclusion Criteria:
* Allergic reaction to sulfur hexafluoride.
* Recent unstable cardiac symptoms.
* Patients with recent coronary intervention (\<7 days)
* Patients with class III and IV heart failure or severe arrhythmias.
* Severe pulmonary hypertension.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
75 Years
Study:
NCT02372695
Study Brief:
Protocol Section:
NCT02372695